Document is current
Any future updates will be listed below
-
Authors
Patterson, Charity G. https://orcid.org/0000-0002-0060-0124
Joslin, Elizabeth
Gil, Alexandra B.
Spigle, Wendy
Nemet, Todd
Chahine, Lana
Christiansen, Cory L.
Melanson, Ed
Kohrt, Wendy M.
Mancini, Martina
Josbeno, Deborah
Balfany, Katherine
Griffith, Garett
Dunlap, Mac Kenzie
Lamotte, Guillaume
Suttman, Erin
Larson, Danielle
Branson, Chantale
McKee, Kathleen E.
Goelz, Li
Poon, Cynthia
Tilley, Barbara
Kang, Un Jung
Tansey, Malú Gámez
Luthra, Nijee
Tanner, Caroline M.
Haus, Jacob M.
Fantuzzi, Giamila
McFarland, Nikolaus R.
Gonzalez-Latapi, Paulina
Foroud, Tatiana
Motl, Robert
Schwarzschild, Michael A.
Simuni, Tanya
Marek, Kenneth
Naito, Anna
Lungu, Codrin
Corcos, Daniel M.
,
Ellis, Terry D.
Shih, Ludy C.
Nordahl, Timothy J.
Stevenson, Michael T.
Alberts, Jay L.
Rao, Ashwini K.
Landis, Corey
Nocera, Joe R.
Hackney, Madeleine E.
Stegemoller, Elizabeth L.
Ridgel, Angela L.
Hondzinski, Jan M.
Johannsen, Neil M.
Drummond, Patrick
Milton, Heather
Hinkle, David A.
Horak, Fay B.
Afshari, Mitra
Hurt, Christopher P.
Kidwell, Ariel
Conroy, Corinna
Panchal, Neil
Schultz, Brooke
Marchbank, Jes
Bloemer, Aaron
Christou, Demetra D.
Vaillancourt, David E.
Lapierre, Stephanie
MacKinnon, Colum D.
Amundsen-Huffmaster, Sommer
Garland, Kristin
Rasmussen, Blake B.
Chapman, Summer
Spahn, Jessica
Wu, Laura
Dibble, Lee E.
Olivier, Genevieve N.
Weltman, Art
Dalrymple, William Alex
Edwards, David
Rynders, Corey
Miller, Lauren
Earhart, Gammon M.
Rawson, Kerri S.
Jones, Kelvin
Nelles, Krista
Almeida, Quincy J.
Saint-Hilaire, Marie
Factor, Stewart A.
Kilbane, Camilla
Copeland, Brian J.
Dale, Marian L.
Espay, Alberto J.
Ramirez-Zamora, Adolfo
Fessenden, Amanda
Deik, Andres F.
Camicioli, Richard
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U01 NS113851)
- License Information
-
More Information
Article History
Received: 27 April 2022
Accepted: 1 September 2022
First Online: 6 October 2022
Declarations
:
: The SPARX3 trial has been approved by the University of Pittsburgh Institutional Review Board Federal Wide Assurance A00006790. Written, informed consent to participate is obtained from all participants.
: A model consent form will be provided upon request to the study PI.
: Oregon Health Sciences University (OHSU) and Dr. Horak have a significant financial interest in APDM Precision Motion, a division of Clario, International that may have a commercial interest in the results of this research and technology. This potential conflict has been reviewed and managed by OHSU. The other authors declare that they have no competing interests.
